Thyro-Tab 0.088 mg., packaged in 150,000-tablet bulk drums for repackaging, RX. The firm name on the label is Lloyd Pharmaceutical, Shenandoah, IA.
Published December 12, 2012 · Recall initiated: July 9, 2012
Summary
FDA records drug Class II recall D-076-2013, published December 12, 2012 and initiated July 9, 2012. Recalling firm: Lloyd Inc. of Iowa; Status: Terminated; Reported quantity: 3,826,269 tablets; Lot: Lot #HA31411 and #HE17811. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
cGMP Deviations; does not meet in process specification requirements
What to do
Voluntary: Firm initiated · Telephone
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Lloyd Inc. of Iowa
- Distributor
- Distribution was nationwide, including Puerto Rico. There was no foreign, military, or government distribution.
- Lot
- Lot #HA31411 and #HE17811
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDALloyd Thyro-Tab 0.050 mg., packaged in 150,000-tablet bulk drums (2/75,000-tablet bags/drum) for repackaging,May 29, 2013
- FDALloyd Thyro-Tab 0.150 mg., packaged in 150,000-tablet bulk drums (2/75,000-tablet bags/drum) for repackaging,May 29, 2013
- FDALevothroid (levothyroxine sodium tablets, USP), 137 mcg, RX only, 100 tablets per bottle, Manufactured forMay 29, 2013
- FDALevothroid (levothyroxine sodium tablets, USP), 112 mcg, RX only, 100 tablets per bottle, Manufactured forMay 29, 2013
- FDALevothroid (levothyroxine sodium tablets, USP), 50 mcg., 100-count bottles, Rx only, NDC 0456-1321-01,December 12, 2012
- FDALevothroid (levothyroxine sodium tablets, USP), 88 mcg., 100-count bottles, Rx only, NDC 0456-1329-01,December 12, 2012
Questions about this recall
Was Thyro-Tab 0.088 mg., packaged in 150,000-tablet bulk drums for repackaging, RX. The firm name on the label is Lloyd Pharmaceutical, Shenandoah, IA. recalled?
Yes. FDA published recall D-076-2013 on December 12, 2012. Reported hazard: cGMP Deviations; does not meet in process specification requirements
What should I do if I have this product?
Voluntary: Firm initiated · Telephone